RGC · NASDAQ · Drug Manufacturers - Specialty & Generic

Regencell Bioscience (RGC)

Develops standardized traditional Chinese medicine formulas for ADHD and autism spectrum disorder.

$6.30
Pre-market+0.03 (+0.48%)
At close$6.27(+14.00%)

Something off on this page? Send us feedback.

Next report
Oct 28, 2026
estimated · in 55 days
EPS estimate
Revenue estimate

EPSReportedEstimate

Jun '26Jun '26Jun '26Jun '26Jun '26Jun '26Jun '26Oct '26
Reported−$0.01−$0.01−$0.01−$0.01−$0.01−$0.01−$0.01Pending
Estimate
Surprise

RevenueReportedEstimate

Jun '26Jun '26Jun '26Jun '26Jun '26Jun '26Jun '26Oct '26
ReportedPending
Estimate
Surprise

History

DateEstimateReportedSurprise
Oct 2026
Jun 2026−$0.01
Jun 2026−$0.01
Jun 2026−$0.01
Jun 2026−$0.01

The latest year is open to everyone — the 15 quarters behind it read with an account.

Sign in
Jun 2026
Jun 2026
Jun 2026
Nov 2025
Oct 2025
Jun 2025
Oct 2024
Jan 2024
Oct 2023
Jan 2023
Oct 2022
Dec 2021
Dec 2020
Jun 2020
Dec 2019
Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Oct 28, 2026
Jun 15, 2026−$0.01−2.1%
Jun 11, 2026−$0.01−4.4%
Jun 10, 2026−$0.01−3.7%
Jun 9, 2026−$0.01+0.7%

The latest year is open to everyone — the 15 quarters behind it read with an account.

Sign in
Jun 8, 2026
Jun 5, 2026
Jun 2, 2026
Nov 18, 2025
Oct 24, 2025
Jun 26, 2025
Oct 25, 2024
Jan 26, 2024
Oct 27, 2023
Jan 30, 2023
Oct 31, 2022
Dec 30, 2021
Dec 30, 2020
Jun 30, 2020
Dec 30, 2019